News

A coordinated FDA initiative and international coalition are advancing non-animal methods in preclinical drug development, accelerating adoption industry-wide.

Telix Pharmaceuticals inaugurated its first Asia-Pacific cyclotron manufacturing facility in Yokohama, Japan, boosting regional radiopharmaceutical production capacity.

Alvotech and Advanz Pharma secured European Economic Area approval for Gobivaz®, a biosimilar to Simponi® (golimumab), expanding access to advanced treatments for immune-mediated diseases.

Novartis received FDA approval for Itvisma, a gene replacement therapy for spinal muscular atrophy, expanding access to a broader patient group in the US.

China launches a dual-track payment model introducing the Commercial Health Insurance Innovative Drug List (CHIIDL), opening new market access and reimbursement channels for innovative medicines.

Europe's leading pharma lab event commences in Düsseldorf, bringing together industry and regulators to advance laboratory analytics, automation, and GMP compliance.

Multi-billion dollar AI drug discovery partnerships and Abbott’s $21B acquisition of Exact Sciences reshape the American pharmaceutical tech landscape.

Increased outsourcing among U.S. pharma and biotech firms is fueling significant expansion in the small molecule CDMO sector, with investments in capacity, compliance, and advanced manufacturing capabilities.

Chinese producers are dramatically cutting prices for pharmaceutical ingredients, disrupting Asia's drug manufacturing landscape and challenging supply chains worldwide.

South Korea’s HIRA debuts a unified, cloud-based system for real-time disclosure of all financial transactions between pharma/device companies and healthcare professionals.